Covid-19
Conditions
Interventions
Initial sample size 90 people, which was divided into four groups
Group 1: Asymptomatic patients, no drug intervention was performed
Group 2: Patients with mild symptoms did not undergo any specific d
Drug
Sponsors
Centro Medico Mazzei
Centro Medico Mazzei
Eligibility
Inclusion criteria
Inclusion criteria: Patients with clinical and epidemiological diagnosis of covid-19 with moderate condition and possible poor prognosis without comorbidities that prevent home treatment.
Exclusion criteria
Exclusion criteria: Do not sign the informed consent form. Present previous heart disease / arrhythmia or associated comorbidity that requires hospital follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Better results with reduced morbidity and mortality with treatment proposed by telemedicine, score of clinical improvement of patients who followed the drug protocol. | — |
Secondary
| Measure | Time frame |
|---|---|
| Analysis of population, symptomatological and epidemiological characteristics related to Covid-19. Analysis of the therapeutic approach by telemedicine. | — |
Countries
Brazil
Contacts
Public ContactMichelle Chechter
Centro Medico Mazzei
Outcome results
None listed